Physician profile
William H Risher
NPI 1669425237
$7,315.43
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,518 · 2020: $612 · 2021: $1,494 · 2022: $906 · 2023: $1,618 · 2024: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328 · Travel and Lodging: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.24 |
| Travel and Lodging | $457.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $3,284.66 | 2019-2023 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Endologix LLC | $814.31 | 2021 | |
| Silk Road Medical, INC. | $761.42 | 2020-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medtronic, INC. | $392.95 | 2021-2023 | Corevalve Evolut R |
| Bolton Medical INC | $350.69 | 2019-2020 | |
| Cook Medical LLC | $307.18 | 2019-2022 | |
| Inari Medical, INC. | $266.00 | 2021 | |
| Medtronic Vascular, INC. | $158.22 | 2019 | |
| Cvrx, INC. | $149.52 | 2023-2024 | Barostim Neo System |
| Abiomed | $130.01 | 2023 | Impella |
| Edwards Lifesciences Corporation | $115.29 | 2024 | Konect Resilia |
| Lantheus Medical Imaging, INC. | $86.92 | 2022 | |
| Artivion, INC. | $65.14 | 2019 | |
| Novartis Pharmaceuticals Corporation | $64.85 | 2022-2023 | |
| Abbott Laboratories | $63.36 | 2023 | Epic |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $59.32 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $44.36 | 2020 | |
| Terumo Medical Corporation | $40.76 | 2019 | |
| Merck Sharp & Dohme LLC | $31.79 | 2023 | Verquvo |
| Lemaitre Vascular, INC. | $19.96 | 2020 | |
| Cardiva Medical, INC. | $19.64 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $18.96 | 2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $16.27 | 2023 | |
| Amgen INC. | $14.58 | 2023 | Repatha |
| Kiniksa Pharmaceuticals, Ltd. | $14.03 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $13.91 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Risher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.